Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-03
2005-05-03
Lambkin, Deborah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S003000
Reexamination Certificate
active
06887894
ABSTRACT:
The use of α-lipoic acid or α-dihydrolipoic acid for increasing the bioavailability of mineral salts, the use of α-lipoic acid or α-dihydrolipoic acid in combination with metal salts, in particular the use of metal α-lipoates, metal α-dihydrolipoates or metal-α-lipoic acid complexes, in particular in mineral preparations or drugs and the metal α-lipoates, metal α-dihydrolipoates or metal-α-lipoic acid complexes themselves are described.
REFERENCES:
patent: 5292538 (1994-03-01), Paul et al.
patent: 5463093 (1995-10-01), Garnett
patent: 5569670 (1996-10-01), Weischer et al.
patent: 5650429 (1997-07-01), Conrad et al.
patent: 5693664 (1997-12-01), Wessel et al.
patent: 5705192 (1998-01-01), Bethge et al.
patent: 5925668 (1999-07-01), Biewenga et al.
patent: 5990152 (1999-11-01), Hettche et al.
patent: 5990153 (1999-11-01), Wood et al.
patent: 6046228 (2000-04-01), Rice et al.
patent: 6127394 (2000-10-01), Pershadsingh et al.
patent: 6235772 (2001-05-01), Packer et al.
patent: 6271254 (2001-08-01), Ulrich et al.
patent: 6288106 (2001-09-01), Pearson et al.
patent: 6313164 (2001-11-01), Fujita et al.
patent: 6331559 (2001-12-01), Bingham et al.
patent: 6348490 (2002-02-01), Hettche et al.
patent: 6369098 (2002-04-01), Pershadsingh et al.
patent: 1668887 (1971-07-01), None
patent: 4419783 (1995-12-01), None
patent: 702953 (1996-03-01), None
patent: 6518 (1968-12-01), None
patent: 0166560 (2001-09-01), None
Roth et al. “Zn-Bindungskapazität des Serums. Ein Parameter zur Diagnose von marginalem Zn-Mangel” Res. Exp. Med. vol. 177 (1980) pp. 213-219.
Sigel “Die hydrophoben und Metallonen-koordinierenden Eigenschaften von α-Liponsäure—ein Biespiel Für intramoleckulare Gleichgewichte in Metallionen-Komplexen” Angew. Chem. vol. 91 (1982) pp. 421-432.
McCormick et al. “Stability and Structure of Binary and Ternary Complexes of α-Lipoate and Lipoate Derivatives with Mn2+, and n2+in Solution1” Archives of Biochemistry and Biophysics vol. 187 (1978) pp. 208-214.
Bonomi et al. “Molecular Aspects of the Removal of Ferritin-bound iron by DL-dihydrolipoate” Biochimica et Biophysica Acta vol. 994 (1989) pp. 180-186.
Strasdeit et al. “Coordination Chemistry of Lipoic Acid and Related Compounds, Part 1 Synthesis and Crystal Structures of the UV- and Light Sensitive Lipoato Complexes [M(lip)2(H2O)2] (M=Zn, Cd)” Z. Narurforsch 52b (1997) pp. 17-24.
Brown et al. “The Reactions of 1,3-Dimercaptopropane, Lipoic Acid and Dihydrolipoic Acid with Metal Ions” J. Inorg. Nucl. Chem. vol. 32 (1970) pp. 2671-2675.
Seal et al. “Effect of Dietary Picolinic Acid on the Metabolism of Exogenous and Endogenous Zinc in the Rat1” J. Nutr. vol. 115 (1985) pp. 986-993.
Schwartz et al. “Zum Einfluβ von Bkiloinsäure und Zitronensäure auf die intestinale Zin-Absorption in vitro und in vivo” Res. Exp. Med vol. 182 (1983) pp. 39-48.
Welch et al. “Effects of Oxalic Acid on Availability of Zinc from Spinach Leaves and Zinc Sulfate to Rats” J. Nutr. vol. 107 (1977) pp. 929-933.
King et al. “Absorption of Stable Isotopes of Iron, Copper, and Zinc during Oral Contraceptive Use” Am. J. of Clin. Nutrition vol. 31 (1978) pp. 1198-1203.
Solomons et al. “Studies on the Bioavailabity of Zinc in man III. Effects of ascorbic acid on zinc absorption” Am J. Clin. Nutrition vol. 32 (1979) pp. 2495-2499.
Sandström et al. “Effect of Ascorbic Acid on the Absorption of Zinc and Calcium in Man” Int. J Vit. Nutr. Res 57 (1987) pp. 87-90.
Palluf et al. “Effekt einer abgestuften Zn-Zufuhr und Zulagen von Cotronensäure zu einer Mais-Soja-Diät auf Leistungparameter und Mineralstoffverwertung beim Ferkel1” J. Amin. Physionl. a. Anim Nutr. vol. 71 (1994) pp. 189-199.
Palluf et al. “Effekt einer Zulage an Citronensäure auf die bioverfügbarkeit von Zink aus Maiskeimen” Z Ernährungswis vol. 29 (1990) pp. 27-38.
Chen et al. “In Vitro Bone Resorption Is Dependent on Physiological Concentations of Zinc” Biological Trace Element Research vol. 61 (1998) pp. 9-18.
Rojas et al. “Relative Bioavailiabity of Two Organic and Two Inorganic Zinc Sources Fed to Sheep” J. Animal Science vol. 75 (1995) pp. 1202-1207.
Wedekind et al. “Bioavailability of Zinc from Inorganic and Organic Sources for Pigs Fed Con-Soybean Meal Diets” J. Anim. Sci. vol. 72 (1994) pp. 2681-2689.
Wedekind et al. “Methodology for Assessing Zinc Bioavaialability: Efficacy Estimates for Zinc-Methionine Zinc Sulfate, and Zinc Oxide” J. Anim. Sci. vol. 70 (1992) pp. 178-187.
Klatt Martin Jochen
Krämer Klaus
BASF - Aktiengesellschaft
Keil & Weinkauf
Lambkin Deborah
LandOfFree
Use of lipoic acid for improving the bioavailability of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lipoic acid for improving the bioavailability of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lipoic acid for improving the bioavailability of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3446010